missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MED15 Monoclonal Antibody (OTI3F1), TrueMAB™, OriGene
Mouse Monoclonal Antibody
Brand: Origene Technologies TA807906S
This item is not returnable.
View return policy
Description
MED15 Monoclonal antibody specifically detects MED15 in Human samples. It is validated for Immunohistochemistry (Paraffin)Specifications
| MED15 | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
| P45379 | |
| Mouse | |
| Affinity chromatography | |
| RUO | |
| 7139 | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| IgG1 |
| Immunohistochemistry (Paraffin) | |
| OTI3F1 | |
| Unconjugated | |
| TNNT2 | |
| A230074L19Rik; Activator-recruited cofactor 105 kDa component; activator-recruited cofactor, 105-kD; ARC105; AW536074; CAG7A; CTG repeat protein 7a; CTG7A; DKFZp686A2214; DKFZp762B1216; FLJ42282; FLJ42935; MED15; Mediator complex subunit 15; mediator of RNA polymerase II transcription subunit 15; mPcqap; PC2 (positive cofactor 2, multiprotein complex) glutamine/Q-rich-associated protein; PC2 glutamine/Q-rich-associated protein; PC2-glutamine-rich-associated protein; PCQAP; Positive cofactor 2 glutamine/Q-rich-associated protein; positive cofactor 2, glutamine/Q-rich-associated protein; positive cofactor 2, multiprotein complex, glutamine/Q-rich-associated protein; TIG1; TIG-1; TNRC7; TPA inducible gene-1; TPA inducible protein; TPA-inducible gene 1 protein; trinucleotide repeat containing 7; trinucleotide repeat-containing gene 7 protein | |
| Full length human recombinant protein of human TNNT2 produced in E.coli. | |
| 30 μL | |
| Primary | |
| Human | |
| Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction